Related Experiment Video
Updated: Feb 18, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
Bharati Kochar1, Edward L Barnes1, Millie D Long1
1Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.
Depression in inflammatory bowel disease (IBD) patients increases their risk of relapse and hospitalization. The Patient Health Questionnaire-8 (PHQ-8) is recommended for assessing depression in IBD care.
Area of Science:
- Gastroenterology
- Psychiatry
- Clinical Research
Background:
- Depression is common in patients with inflammatory bowel disease (IBD).
- The impact of depression on IBD disease activity and progression is not well understood.
- Current methods for assessing depression in IBD patients are inadequate.
Purpose of the Study:
- To evaluate the association between baseline depression and IBD disease activity at follow-up.
- To assess the effectiveness of the Patient Health Questionnaire-8 (PHQ-8) in identifying depression among IBD patients.
- To provide guidance for healthcare providers on depression assessment in IBD.
Main Methods:
- Utilized data from the Sinai-Helmsley Alliance for Research Excellence cohort.
- Assessed depression using the PHQ-8, with a score ≥5 indicating mild depression.
- Analyzed associations between baseline depression and IBD relapse, surgery, or hospitalization using binomial regression.
Main Results:
- Higher prevalence of depression detected by PHQ-8 (38% in Crohn's disease, 32% in ulcerative colitis) compared to self-report.
- Patients with Crohn's disease and baseline depression had increased risk of relapse (RR: 2.3) and hospitalization/surgery (RR: 1.3).
- Patients with ulcerative colitis and baseline depression had increased risk of hospitalization/surgery (RR: 1.3).
Conclusions:
- Baseline depression is a significant risk factor for more aggressive IBD outcomes.
- A single-question depression screening is insufficient for IBD patients.
- Routine administration of the PHQ-8 is recommended for identifying at-risk IBD patients.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

